Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference41 articles.
1. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets;Rix;Blood,2007
2. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors;Bantscheff;Nat Biotechnol,2007
3. Dasatinib suppresses in vitro natural killer cell cytotoxicity;Blake;Blood,2008
4. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo;Fraser;Exp Hematol,2009
5. The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity;Salih;Int J Cancer,2010
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia;Blood;2024-08-08
2. NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment;Immunology;2024-02-15
3. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11
4. Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer;Vaccines;2022-11-23
5. NK Cells in Myeloproliferative Neoplasms (MPN);Cancers;2021-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3